FILE PHOTO: A Gilead Sciences Inc. office is shown in Foster City, California, US May 1, 2018. [Reuters]
More than two-thirds of severely ill Covid-19 patients saw their condition improve after treatment with remdesivir, an experimental drug being developed by Gilead Sciences Inc. (GILD.O), according to new data based on patient observation.